Skip to main content
Caplight Logo









Celliaz Co., Ltd.

Celliaz Co., Ltd.

Private
DaejeonHealthcare & Life Scienceshttps://celliaz.com

Last Round

Seed

Sep 1, 2022

Company Overview

Celliaz Co., Ltd. operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a Seed round in September 2022.

Celliaz Co., Ltd. is a biotechnology company that develops homeoprotein-based retinal regeneration therapies for degenerative retinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Celliaz Co., Ltd. Comparables

Compare Celliaz Co., Ltd. with similar companies based on industry and business-model similarity.

Celliaz Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Olive Bio Therapeutics
86%
Ray Therapeutics
77%
Atsena Therapeutics
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Celliaz Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Celliaz Co., Ltd. Investors

Notable investors and investment history

Celliaz Co., Ltd. investors
InvestorRounds
GenaxisSeed
FuturePlaySeed
IBK ChanggongSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2022

    Seed round raised with participation from Genaxis, FuturePlay, IBK Changgong, and Seoul Biohub.

Book a demo to see all signals

For institutional investors. Book with your work email.

Celliaz Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Celliaz Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Celliaz Co., Ltd.'s valuation, stock price, and market status.

Is Celliaz Co., Ltd. a public or private company?

Celliaz Co., Ltd. is a private company.

What is the current stock price of Celliaz Co., Ltd.?

Celliaz Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Celliaz Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Celliaz Co., Ltd. worth (valuation)?

Valuation information for Celliaz Co., Ltd. is not publicly available.

Can I buy Celliaz Co., Ltd. stock?

Celliaz Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Celliaz Co., Ltd.'s last funding round?

Celliaz Co., Ltd.'s most recent funding round was Seed on September 1, 2022.

Who are the main investors in Celliaz Co., Ltd.?

Key investors in Celliaz Co., Ltd. include Genaxis, FuturePlay, IBK Changgong.

Will Celliaz Co., Ltd. IPO soon?

No public IPO plans have been announced for Celliaz Co., Ltd..

How can I track Celliaz Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Celliaz Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersDaejeon
Year Founded2022
Last FundingSep 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?